Skip to main content
Header image
User picture
Groups: CATRIN, IMTM, LEM, STAFF

Journals

CBL-B – An upcoming immune-oncology target. Expert Opinion on Therapeutic Patents. 2024, ISSN: 1354-3776, PMID: 39582379,  PDF.
Reaction-manifold diversion enables general access to oxa-β-lactam chemical space. Organic Chemistry Frontiers. 2026, 13(21), 7750-7759, ISSN: 2052-4129,  PDF.